Topical Lidocaine Anesthesia for Nasopharyngeal Sampling
- Conditions
- Nasopharyngeal SamplingLocal Anesthesia
- Interventions
- Other: Placebo
- Registration Number
- NCT04885777
- Lead Sponsor
- Ataturk University
- Brief Summary
Introduction: Nasopharyngeal sampling is widely used in the diagnosis of the Coronavirus Disease 2019 (COVID-19). The aim of this study is to evaluate the effects of topical lidocaine application for nasopharyngeal sampling, on pain perception, the comfort of the patients, and the application difficulty for healthcare staff.
Methods: This study is a prospective randomized placebo-controlled study conducted with 100 healthy volunteers (50 participants in Lidocaine group and 50 participants in Placebo group). Two ml of a solution containing 10 mg/ml of lidocaine was applied to each nostril of the participants in the Lidocaine group, and the same dose of 0.9% NaCl to the Placebo group. Investigators performed two repeated sampling one hour apart. The first sampling was performed before intervention, and the second was performed five-minutes after intervention. Investigators compared the changes in pain intensity and discomfort intensity using two numerical rating scales, the frequency of undesirable reactions, and the judgment of the practitioner staff about the sampling procedure between first and second sampling.
- Detailed Description
This study is a prospective randomized placebo-controlled study with restricted randomization of an allocation ratio of 1:1. We used Random Allocation Software (RAS) for randomization. The study is conducted following the CONSORT guideline and the tenets of the Declaration of Helsinki we obtained the approval of the Ataturk University Clinical Research Ethics Committee. Also, the written informed consent of all participants will obtained.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 50
The inclusion criteria of the study is:
- being 18 years and older
- volunteering to participate in the study.
-
The exclusion criteria of the study is:
- taking analgesic drugs before admission,
- pregnancy,
- lactation,
- having a bleeding disorder, *known allergy to Lidocaine, * previous nasal trauma or operation,
- having respiratory tract infection symptoms (such as fever, headache, runny nose, sore throat, cough, sneeze, breathlessness),
- having a chronic disease (diabetes, cancer, heart disease, asthma, COPD, etc.).
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Lidocaine group Lidocaine One ml of a solution containing 20 mg/ml of lidocaine was applied to each nostril of the participants in the Lidocaine group. Thus, a total of 40 mg of lidocaine, 20 mg for each nostril, was given to the individuals of the Lidocaine group. Placebo group Placebo The Placebo group received only a total of 2 ml of 0.9% NaCl (one ml for each nostril).
- Primary Outcome Measures
Name Time Method Changes in the severity of pain during the sampling procedure. 2 hours This outcome will measured via a paper questionnaire that had two Numerical Rating Scale (NRS). The NRSs were 100 mm scales ranging from 0 to 10 (0 as the absence of pain/discomfort and 10 as unbearable pain/discomfort).
Changes in the severity of discomfort during the sampling procedure. 2 hours This outcome will measured via a paper questionnaire that had two Numerical Rating Scale (NRS). The NRSs were 100 mm scales ranging from 0 to 10 (0 as the absence of pain/discomfort and 10 as unbearable pain/discomfort).
Changing the frequency of undesirable reactions 2 Hours Changing the frequency of undesirable reactions during between first and second sample collection. We will record head retraction, holding practitioner staff's hand, grimace, cough, and sneeze as the undesirable reaction during the sampling procedure.
Judgment of the practitioner staff about the sampling procedure 2 Hours We will research the appropriateness and the difficultness of the sample collection procedure, for this outcome. If four steps of the sampling procedure (inserting in the nostril, hitting the back of the nasopharyngeal cavity, rotating five times, and removing) have been completed successfully, it will be defined as the sampling procedure is as appropriate.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Ataturk University
🇹🇷Erzurum, Turkey